Programmable Bacterial Architects Crafting Sonosensitizers for Tumor‐Specific Sonodynamic Immunotherapy
Advanced Materials · 2025-08 · 37 (32)
DOI: 10.1002/adma.202504206 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 22.05.2025. Verfasst von Zuo Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Lab of Molecular Imaging and Translational Medicine (MITM), Engineering Research Center of Molecular & Neuroimaging, Ministry of Education, School of…. Hauptthemen laut MEDLINE: Immunotherapy, Escherichia coli, Photosensitizing Agents, Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Key Research and Development Program of Shaanxi, Shaanxi Fundamental Science Research Project for Chemistry and Biology.
Abstract (Originalsprache)
Sonodynamic therapy (SDT) is a non‐invasive cancer treatment that uses ultrasound to activate sonosensitizers for selective tumor ablation. With its superior tissue penetration compared to photodynamic therapy, SDT demonstrates the potential to stimulate antitumor immune responses by modulating the tumor microenvironment. However, its clinical application remains limited by poor tumor specificity and suboptimal sonosensitizer accumulation, which reduces efficacy and causes off‐target effects. To address these challenges, an Engineered Probiotic‐based Calibrated 5‐ALA Supply system (SPEC5) is developed to confer tumor selectivity for SDT. Engineered non‐pathogenic E. coli with recombinant plasmids enables efficient 5‐ALA biosynthesis through kinetic remodeling. Homologous tumor cell membrane cloaking further enhances tumor targeting and immune evasion. Upon intravenous injection, SPEC5 selectively colonizes in the tumor, supporting the sonosensitizer protoporphyrin IX (PpIX) in situ biosynthesis via 5‐aminolevulinic acid (5‐ALA) continuous supply. A hypoxia‐inducible promoter regulating O‐acetylserine sulfhydrylase ensures the tumor specificity of PpIX production. This system achieves robust sensitizer accumulation in tumors, enhancing SDT efficacy and inducing potent antitumor immune activation with minimal systemic toxicity. Post‐treatment, the bacteria are rapidly cleared to ensure safety. This study presents a novel strategy for tumor‐specific sonosensitizer supply, revolutionizing 5‐ALA‐based SDT and paving the way for advanced tumor‐targeted therapies with enhanced immunotherapeutic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lab of Molecular Imaging and Translational Medicine (MITM), Engineering Research Center of Molecular & Neuroimaging, Ministry of Education, School of Life Science and Technology, Xidian University, Xi'an, Shaanxi, 71012…
ORCID-Profile: Zhongliang Wang
Förderung
- National Key Research and Development Program of China
- Key Research and Development Program of Shaanxi
- Shaanxi Fundamental Science Research Project for Chemistry and Biology
- Xidian University Specially Funded Project for Interdisciplinary Exploration
- China Postdoctoral Science Foundation
- Postdoctoral Research Project of Shaanxi Province
- National Natural Science Foundation of China
- Natural Science Basic Research Program of Shaanxi Province
Zitieren
APA
Yang, Z., Jiao, Z., Chen, Z., Qiao, C., Huang, C., Wang, L., Rao, Z., Zhang, R., & Wang, Z. (2025). Programmable Bacterial Architects Crafting Sonosensitizers for Tumor‐Specific Sonodynamic Immunotherapy. Advanced Materials, 37(32). https://doi.org/10.1002/adma.202504206
Vancouver
Yang Z, Jiao Z, Chen Z, Qiao C, Huang C, Wang L, et al. Programmable Bacterial Architects Crafting Sonosensitizers for Tumor‐Specific Sonodynamic Immunotherapy. Advanced Materials. 2025;37(32). doi:10.1002/adma.202504206
BibTeX
@article{Yang2025,
author = {Yang, Zuo and Jiao, Zhiping and Chen, Zhuang and Qiao, Chaoqiang and Huang, Chuting and Wang, Lingyun and Rao, Zhiping and Zhang, Ruili and Wang, Zhongliang},
title = {Programmable Bacterial Architects Crafting Sonosensitizers for Tumor‐Specific Sonodynamic Immunotherapy},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {32},
doi = {10.1002/adma.202504206}
}
EUVIMED